• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期卡托普利治疗对心肌梗死和心力衰竭大鼠的血流动力学益处及生存期延长作用。

Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.

作者信息

Pfeffer J M, Pfeffer M A, Braunwald E

出版信息

Circulation. 1987 Jan;75(1 Pt 2):I149-55.

PMID:3539404
Abstract

To determine whether the hemodynamic profile of chronic heart failure secondary to myocardial infarction could be altered, captopril was administered to female Wistar rats 3 weeks after coronary artery ligation and continued for 3 months. Captopril reduced left ventricular mass, prevented the increase in right ventricular mass observed with increasing infarct size, lessened the increase in left ventricular end-diastolic pressure, and reduced mean arterial pressure and total peripheral resistance, whereas cardiac output and heart rate were maintained. The end-diastolic volume of treated rats with moderate infarcts was significantly less than that of untreated rats, and therefore the ejection fraction index was significantly increased. In rats given captopril until death or for a period of up to 1 year, survival was significantly prolonged, particularly in those rats with moderate-sized infarcts.

摘要

为了确定心肌梗死后慢性心力衰竭的血流动力学特征是否可以改变,在冠状动脉结扎3周后给雌性Wistar大鼠服用卡托普利,并持续3个月。卡托普利可减轻左心室重量,防止随着梗死面积增大而出现的右心室重量增加,减轻左心室舒张末期压力的升高,并降低平均动脉压和总外周阻力,而心输出量和心率保持不变。中度梗死的治疗组大鼠的舒张末期容积明显小于未治疗组大鼠,因此射血分数指数显著升高。在给予卡托普利直至死亡或长达1年的大鼠中,生存期显著延长,尤其是那些中度梗死的大鼠。

相似文献

1
Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.长期卡托普利治疗对心肌梗死和心力衰竭大鼠的血流动力学益处及生存期延长作用。
Circulation. 1987 Jan;75(1 Pt 2):I149-55.
2
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.慢性卡托普利治疗对大鼠梗死左心室的影响。
Circ Res. 1985 Jul;57(1):84-95. doi: 10.1161/01.res.57.1.84.
3
Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.卡托普利治疗可改善心肌梗死所致心力衰竭时肌浆网的钙转运。
J Mol Cell Cardiol. 1999 Sep;31(9):1663-72. doi: 10.1006/jmcc.1999.1000.
4
Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.静脉注射卡托普利对大鼠心肌梗死和心力衰竭模型的急性局部血管效应。
J Pharmacol Exp Ther. 1987 Apr;241(1):13-9.
5
Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.阿曲普利(一种心房肽酶和血管紧张素I转换酶的混合抑制剂)对心肌梗死大鼠心脏肥大和激素反应的影响。与卡托普利的比较。
J Pharmacol Exp Ther. 1994 Jul;270(1):8-14.
6
Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.新型血管肽酶抑制剂sampatrilat对左冠状动脉结扎所致慢性心力衰竭大鼠心脏重塑和功能的有益作用。
J Pharmacol Exp Ther. 2003 Apr;305(1):97-105. doi: 10.1124/jpet.102.042747.
7
Converting-enzyme inhibitor therapy for chronic heart failure.慢性心力衰竭的转换酶抑制剂治疗
Herz. 1983 Apr;8(2):71-80.
8
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.选择性If电流抑制剂伊伐布雷定所致的长期心率降低可改善充血性心力衰竭患者的左心室功能和心肌固有结构。
Circulation. 2004 Apr 6;109(13):1674-9. doi: 10.1161/01.CIR.0000118464.48959.1C. Epub 2004 Feb 23.
9
Ventricular enlargement and reduced survival after myocardial infarction.心肌梗死后心室扩大与生存率降低
Circulation. 1987 May;75(5 Pt 2):IV93-7.
10
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).在急性心肌梗死后出现左心室收缩功能障碍、心力衰竭或两者皆有的老年患者中,尽管接受了卡托普利和/或缬沙坦治疗,其死亡率和发病率仍然很高:缬沙坦急性心肌梗死试验(VALIANT)的结果。
Circulation. 2005 Nov 29;112(22):3391-9. doi: 10.1161/CIRCULATIONAHA.105.551143. Epub 2005 Nov 21.

引用本文的文献

1
Cardioprotective Role of Captopril: From Basic to Applied Investigations.卡托普利的心脏保护作用:从基础研究到应用研究
Int J Mol Sci. 2025 Jul 25;26(15):7215. doi: 10.3390/ijms26157215.
2
Foreword.前言。
Interv Cardiol. 2017 May;12(Suppl 1):4-22. doi: 10.15420/icr.2017.12.1.S1.
3
Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography-a subanalysis of the EMPAG-HF trial.恩格列净对左心房和心室充盈参数的急性影响:采用超声心动图的研究——EMPA - HF试验的亚组分析
Eur Heart J Cardiovasc Pharmacother. 2025 Mar 13;11(2):190-197. doi: 10.1093/ehjcvp/pvaf003.
4
Platelet and Erythrocyte Membranes Coassembled Biomimetic Nanoparticles for Heart Failure Treatment.血小板和红细胞膜共组装仿生纳米颗粒用于心力衰竭治疗。
ACS Nano. 2024 Oct 1;18(39):26614-26630. doi: 10.1021/acsnano.4c04814. Epub 2024 Aug 22.
5
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.血管紧张素 II 诱导的心肌肥厚信号转导机制。
Cells. 2022 Oct 22;11(21):3336. doi: 10.3390/cells11213336.
6
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.BET溴结构域抑制可抑制心力衰竭中的先天性炎症和促纤维化转录网络。
Sci Transl Med. 2017 May 17;9(390). doi: 10.1126/scitranslmed.aah5084.
7
Changes in β-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.心肌梗死后心力衰竭时β肾上腺素受体的变化可被肾素-血管紧张素系统阻断所减弱。
Mol Cell Biochem. 2004 Aug;263(1):11-20. doi: 10.1023/B:MCBI.0000041844.24424.35.
8
Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.慢性给予小促红细胞生成素非肽序列可有效改善心肌梗死后扩张型心肌病的进展。
J Pharmacol Exp Ther. 2013 Jun;345(3):446-56. doi: 10.1124/jpet.113.202945. Epub 2013 Apr 12.
9
Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.β1-肾上腺素能受体(AR)阻滞剂与β2-AR激动剂联合用药对大鼠心肌梗死后扩张型心力衰竭模型的治疗效果优于β1-AR阻滞剂加血管紧张素转换酶抑制剂。
J Pharmacol Exp Ther. 2009 Oct;331(1):178-85. doi: 10.1124/jpet.109.157107. Epub 2009 Jul 8.
10
Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.氯沙坦可降低p42/44丝裂原活化蛋白激酶信号传导,并维持亮氨酸拉链(LZ)+肌球蛋白磷酸酶靶向亚基1(MYPT1)的表达。
PLoS One. 2009;4(4):e5144. doi: 10.1371/journal.pone.0005144. Epub 2009 Apr 9.